You have 9 free searches left this month | for more free features.

Chronic Lymphocytic Leukemia

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial (Nemtabrutinib, Fludarabine, Cyclophosphamide)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Leukemia
  • (no location specified)
Nov 30, 2022

Chronic Lymphocytic Leukemia, Richter Syndrome, Small Lymphocytic Lymphoma Trial in Rochester (Acalabrutinib, Durvalumab,

Recruiting
  • Chronic Lymphocytic Leukemia
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial in Scottsdale, Rochester (Biospecimen Collection, Cardiopulmonary

Recruiting
  • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
  • Biospecimen Collection
  • +8 more
  • Scottsdale, Arizona
  • +1 more
May 16, 2023

Orelabrutinib in the Treatment of CLL/SLL

Not yet recruiting
  • CLL/SLL
    • (no location specified)
    Jul 26, 2023

    Chronic Lymphocytic Leukemia (CLL), Waldenstrom Macroglobulinemia (WM) Trial in Rochester (Shingrix vaccine)

    Completed
    • Chronic Lymphocytic Leukemia (CLL)
    • Waldenstrom Macroglobulinemia (WM)
    • Shingrix vaccine
    • Rochester, New York
      University of Rochester
    Jan 9, 2023

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Scottsdale, Jacksonville, Rochester (drug, other, biological)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Scottsdale, Arizona
    • +2 more
    Jan 5, 2023

    B Cell Repertoires in Chronic Lymphocytic Leukemia and Aging

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
      • Manhasset, New York
        Feinstein Institute for Medical Research
      Jul 6, 2022

      Unfit CLL Included in GIMEMA LLC1114 Trial Who Discontinued

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • Observation
      • (no location specified)
      Oct 12, 2023

      Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Untreated Chronic Lymphocytic Leukemia Trial in Topeka, Omaha

      Active, not recruiting
      • Chronic Lymphocytic Leukemia
      • +3 more
      • Cholecalciferol
      • Laboratory Biomarker Analysis
      • Topeka, Kansas
      • +1 more
      Aug 4, 2022

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Duarte (procedure, biological, drug)

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • Biospecimen Collection
      • +4 more
      • Duarte, California
        City of Hope Medical Center
      Jan 30, 2023

      Leukemia, Lymphoma Trial in Houston (Rituximab, Lenalidomide)

      Active, not recruiting
      • Leukemia
      • Lymphoma
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Oct 11, 2022

      Chronic Lymphocytic Leukemia Trial in Salt Lake City (RP-3500 in combination with Olaparib)

      Recruiting
      • Chronic Lymphocytic Leukemia
      • RP-3500 in combination with Olaparib
      • Salt Lake City, Utah
        Huntsman Cancer Institute at the University of Utah
      Sep 23, 2022

      Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic, Leukemia, B-cell Trial in Whittier (Pirtobrutinib, Ibrutinib)

      Recruiting
      • Chronic Lymphocytic Leukemia
      • +3 more
      • Whittier, California
        Innovative Clinical Research Institute
      Aug 8, 2022

      ITGA4 Gene Methylation Status in Chronic Lymphocytic Leukemia

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
        • (no location specified)
        May 7, 2022

        Chronic Lymphocytic Leukemia Trial (Evaluation of response to treatment with response-tailored Ibrutinib in patients with

        Not yet recruiting
        • Chronic Lymphocytic Leukemia
        • Evaluation of response to treatment with response-tailored Ibrutinib in patients with chronic lymphocytic leukemia
        • (no location specified)
        Dec 27, 2022

        Hypogammaglobulinemia, Bacterial Infections, B-cell Chronic Lymphocytic Leukemia Trial in Columbus, Pittsburgh (Xembify,

        Recruiting
        • Hypogammaglobulinemia
        • +2 more
        • Columbus, Ohio
        • +1 more
        Jan 16, 2023

        Chronic Lymphocytic Leukemia Trial in Portland (drug, procedure, biological, other)

        Not yet recruiting
        • Chronic Lymphocytic Leukemia
        • Portland, Oregon
          OHSU Knight Cancer Institute
        Jul 12, 2023

        Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome Trial in Italy, United Kingdom, United States

        Active, not recruiting
        • Chronic Lymphocytic Leukemia
        • +3 more
        • Boston, Massachusetts
        • +11 more
        Nov 23, 2022

        Venetoclax Resistance Landscape in Chronic Lymphocytic Leukemia

        Recruiting
        • Chronic Lymphocytic Leukemia
        • +4 more
          • Bobigny, France
          • +8 more
          Mar 23, 2022

          B-cell Chronic Lymphocytic Leukemia Trial in Peking (Alemtuzumab)

          Suspended
          • B-cell Chronic Lymphocytic Leukemia
          • Alemtuzumab
          • Peking, Beijing, China
            Peking University Cancer Hospital
          Jun 15, 2022

          Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

          Recruiting
          • Recurrent Chronic Lymphocytic Leukemia
          • +3 more
          • Houston, Texas
            M D Anderson Cancer Center
          Aug 17, 2022

          Small Lymphocytic Lymphoma, CLL (Chronic Lymphocytic Leukemia) Trial run by the National Heart, Lung, and Blood Institute

          Active, not recruiting
          • Small Lymphocytic Lymphoma
          • CLL (Chronic Lymphocytic Leukemia)
          • Fludarabine Phosphate
          • +2 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          Oct 13, 2022

          B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine

          Not yet recruiting
          • B-cell Non Hodgkin Lymphoma
          • Chronic Lymphocytic Leukemia
          • Cyclophosphamide injection
          • +2 more
          • Charleston, South Carolina
            Hollings Cancer Center at Medical University of South Carolina
          Jan 18, 2023

          Relapsed Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia Trial in Poland, United

          Recruiting
          • Relapsed Non Hodgkin Lymphoma
          • +6 more
          • Cincinnati, Ohio
          • +4 more
          Aug 3, 2022